Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
Thomson
Essential Science Indicators - Special Topics  RSS feeds for the editorial Web sites of Essential Science Indicators.
All Topics Menu
Help || About || Contact

  
|  Previous Page  |
  |  Special Topics Menu  |  |  Next Page  |
  

Hepatitis C Methodology
Publication Date: September 2002
Citing URL: http://esi-topics.com/hepc

Hepatitis C

The baseline time span for this database is 1992 - 2002. The resulting database contained 17,872 papers; 35,896 authors; 140 countries; 1,003 journals; and 7,780 institutions. Read the methodology used to create this special topic.
M
Top Papers
Top 25 papers overall
1992 - June 2002
Top Authors
Top 25 overall
1992 - June 2002
Top Institutions
Top 25 overall
1992 - June 2002
Top Nations
Top 25 overall
1992 - June 2002
Top Journals
Top 25 overall
1992 - June 2002
Time Series
1 year
5 year
Field Representation, Distribution
Field representation
1992 - June 2002
Editorial
Read interviews and first-person essays about people in a wide variety of fields, and information on journals in the topic of Hepatitis C.
October 2002
Dr. Christian Bréchot
September 2002
Abstract of the Top Paper
E
N
U

Overview

Hepatitis C, the most severe of the five known hepatitis viruses, is the most common blood-borne infection in the United States. People with hepatitis C can experience liver cirrhosis, liver cancer, and liver failure. The top 25 papers in hepatitis C research over the past decade cover a wide variety of issues, from genotyping to treatment. Methods for genotyping or testing various aspects of the virus covered in this listing include the polymerase chain reaction, phylogenetic analysis of nucleotide sequences, branched DNA signal amplification, and the line probe assay. Nomenclature systems for the various viral genotypes are also discussed. The predominant treatment papers involve clinical trials of interferon alpha-2b alone or in combination with ribavirin. Other topics in the top 25 include: the natural history of community-acquired hepatitis C; transmission of the virus from mothers to infants; immune selection; re-infection; the status of post-transfusion risk factors; association of hepatitis C with other illnesses, such as type II cryoglobulinemia and membranoproliferative glomerulonephritis; and the pathogenic role of intrahepatic cytotoxic lymphocytes.

Methodology

To construct this database, papers were extracted based on title- and author-supplied keywords for Hepatitis C. The keywords used were as follows: 

HEPATITIS-C
HEPATITIS-C-ASSOCIATED
HEPATITIS-C-INFECTED
HEPATITIS-C-RELATED
HEPATITIS-C-VIRUS

AUTHOR KEYWORDS STEM-SEARCHED

HEPATITIS C
HEPATITIS-C

The baseline time span for this database is 1992 - 2002. The resulting database contained 17,872 papers; 35,896 authors; 140 countries; 1,003 journals; and 7,780 institutions.

Rankings

Once the database was in place, it was used to generate the lists of top 25 papers, authors, journals, institutions, and nations, covering a time span of 1992 - 2002 (weeks 1-26).

The top 25 papers are ranked according to total cites. Rankings for author, journal, institution, and country are listed in three ways: according to total cites, total papers, and total cites/paper. The paper thresholds used to determine scientist, institution, country, and journal rankings according to total cites/paper were as follows: 46, 33, 33, and 30, respectively.

Return to Menu Return to Menu

 

Hepatitis C Menu || All Topics Menu
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.